TRIAL DESIGN PLATFORM
    5.
    发明申请

    公开(公告)号:US20210241860A1

    公开(公告)日:2021-08-05

    申请号:US17163425

    申请日:2021-01-30

    申请人: Cytel Inc.

    IPC分类号: G16H10/20 G06F30/20

    摘要: A method for determining trial designs is provided. The method includes receiving, via at least one processor, one or more trial design criteria and one or more scenarios corresponding to a set of trial designs, and generating, via the at least one processor, simulation data based at least in part on replicating each of the set of trial designs with the one or more trial design criteria and the one or more scenarios. The simulation data includes performance parameters and performance parameter values associated with each design in the set of designs for a set of criteria. The method further includes determining, via the at least one processor, an optimality criteria for evaluating the trial designs, searching, within the set of trial designs, via the at least one processor, for globally optimum designs based on the optimality criteria, and transmitting, via the at least one processor, globally optimum designs.

    Use of trans-sialidase and sialyltransferase for synthesis of
sialyl.alpha.2.fwdarw.3.beta.galactosides
    7.
    发明授权
    Use of trans-sialidase and sialyltransferase for synthesis of sialyl.alpha.2.fwdarw.3.beta.galactosides 失效
    使用唾液酸酶和唾液酸转移酶合成唾液酸α2->3β半乳糖苷

    公开(公告)号:US5409817A

    公开(公告)日:1995-04-25

    申请号:US57528

    申请日:1993-05-04

    摘要: A single vessel cyclic synthesis process for preparation of a sialyl.alpha.2.fwdarw.3.beta.galactoside is disclosed. In accordance with this process, a sialyltransferase acceptor is sialylated in an aqueous reaction medium by an .alpha.(2,3)sialyl transferase and CMP-sialic acid to form a sialyl donor substrate and CMP. In the presence of the trans-sialidase of Trypanosoma crusi, that sialyl donor substrate provides a sialyl group for a trans-sialidase acceptor, thereby preparing the sialyl.alpha.2.fwdarw.3.beta.galactoside. The .alpha.(2,3)sialyltransferase acceptor is reformed upon trans-sialidation of the latter acceptor, and the sialyl donor substrate is reformed using the .alpha.(2,3)sialyltransferase and a CMP-sialic acid recycling system that combines CMP with sialic acid that is also present in the vessel. The K.sub.m /V.sub.max value for the .alpha.(2,3)sialyltransferase acceptor is less than one-tenth the value of K.sub.m /V.sub.max of the trans-sialidase acceptor for the .alpha.(2,3)sialyltransferase.

    摘要翻译: 公开了用于制备唾液酸α2->3β半乳糖苷的单容器循环合成方法。 根据该方法,唾液酸转移酶受体通过α(2,3)唾液酸转移酶和CMP-唾液酸在水性反应介质中唾液酸化以形成唾液酸供体底物和CMP。 在克氏锥虫的唾液酸酶的存在下,唾液酸供体底物为唾液酸酶受体提供唾液酸基,从而制备唾液酸α2->3β半乳糖苷。 将α(2,3)唾液酸转移酶受体通过后一个受体的反式唾液酸化进行重组,并且使用α(2,3)唾液酸转移酶和将CMP与唾液酸组合的CMP-唾液酸回收系统重组唾液酸供体底物 这也存在于船上。 α(2,3)唾液酸转移酶受体的Km / Vmax值小于α(2,3)唾液酸转移酶的唾液酸酶受体的Km / Vmax值的十分之一。

    SYSTEMS AND METHODS FOR TRADE-OFF VISUAL ANALYSIS

    公开(公告)号:US20220374558A1

    公开(公告)日:2022-11-24

    申请号:US17847040

    申请日:2022-06-22

    申请人: Cytel Inc.

    IPC分类号: G06F30/12 G06F30/20

    摘要: A method for trial design analysis that includes receiving, for each trial design of a plurality of trial designs, a set of simulated performance criteria for a set of trial designs, and visualizing, on a graph, values for a first simulated performance criteria and a second simulated performance criteria from the set of simulated performance criteria for each trial design using a location of points on the graph corresponding to the set of trial designs. The method further includes identifying optimal designs based on an optimality criteria using the set of the simulated performance criteria, and determining a tradeoff metric for the first simulated performance criteria and the second simulated performance criteria. The method further includes displaying, the tradeoff metric as a set of lines on the graph, wherein a slope of the lines corresponds to a value of the tradeoff metric.